| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 55 |
| Sex | Both Genders |
| Age Range | 45-64, 65+ |
| Body Types | Obese, Overweight |
Supplementation of 500mg of either alpha-tocopherol itself or mixed tocopherols noted that both treatments were able to reduce serum F2-isoprostanes without any influence on urinary F2-isoprostanes or red blood cell antioxidants. Other parameters, with the exception for less leukotriene B4 from neutrophils seen with mixed tocopherols, were affected.
